NCT01222520 - Telmisartan 80mg Non-responder Trial | Biotech Hunter

Enrollment

174

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

June 30, 2011

Conditions

Hypertension

Interventions

DRUG

Telmisartan and amlodipine

Telmisartan 80 mg and amlodipine 5 mg once a daily

DRUG

Telmisartan

80 mg once a daily

Trial Locations (4)

1235.36.01 Boehringer Ingelheim Investigational Site, Chuo-ku,Tokyo

1235.36.04 Boehringer Ingelheim Investigational Site, Hiroshima, Hiroshima

1235.36.02 Boehringer Ingelheim Investigational Site, Shinjuku-ku, Tokyo

1235.36.03 Boehringer Ingelheim Investigational Site, Suita, Osaka